The contract also supports the research on plasminogen activator (TPA) and Silabilin as MCM’s against sulfur mustard gas exposure.
AEOL can also be used to treat pulmonary injuries resulting from exposure to radiation.
NJH intends to run efficacy studies in the rat model for higher doses of sulfur mustard and chlorine gas besides establishing endpoints, optimal dosing and duration of treatment for pivotal efficacy studies.
The earlier work that has demonstrated the efficacy of AEOL in protecting the lungs from damage due to inhalation of chlorine gas and sulfur mustard gas will support the new study.